86.22.Z - Specialist medical practice activities
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
46.46.Z - Wholesale of pharmaceutical goods
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
86.21.Z - General medical practice activities
86.23.Z - Dental practice activities
86.90.A - Physiotherapeutical activities
86.90.C - Nurses and midwives activities
86.90.E - Other human health activities notelsewhere classified
2022 | 2023 | ||
---|---|---|---|
K PLN | K PLN | % | |
Gross profit (loss) | 24,2 | 139,9 | 477,7 |
EBITDA | 24,2 | 151,3 | 524,8 |
Short time liabilities | 21,3 | 42,2 | 98,5 |
Equity capital | 26,4 | 151,8 | 475,5 |
Operating profit (EBIT) | 24,2 | 139,9 | 477,7 |
Assets | 47,7 | 194,1 | 307,2 |
Net profit (loss) | 21,4 | 125,5 | 486,6 |
Cash | 45,6 | 143,2 | 214,1 |
Net income from sale | 267,1 | 600,3 | 124,8 |
Liabilities and provisions for liabilities | 21,3 | 42,2 | 98,5 |
Working assets | 47,7 | 148,5 | 211,5 |
Depreciation | 0 | 11,4 | -∞ |
% | % | p.p. | |
Profitability of capital | 81,1 | 82,6 | 1,5 |
Equity capital to total assets | 55,4 | 78,2 | 22,8 |
Gross profit margin | 9,1 | 23,3 | 14,2 |
EBITDA Margin | 9,1 | 25,2 | 16,1 |
Days | Days | Days | |
Short term commitment turnover cycle | 29 | 26 | -3 |
Current financial liquidity indicator | 2.2401835918426514 | 3.5152339935302734 | 1,3 |
Net dept to EBITDA | -1.8826593160629272 | -0.9001356363296509 | 1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane